Frontlight ResearchEarly access
Chronic kidney disease trials in Armenia
1 of 1 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
- Where
- Yerevan
- Age
- 18 years and over
- People
- 429 worldwide
- Run by
- Genexine, Inc.
See details and how to joinNCT06466785